Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions - Wikidata - awgldk - TriplyDB

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

http://www.wikidata.org/entity/Q34992760

about

Interventions for treating intrahepatic cholestasis in people with sickle cell disease Antibiotics for treating acute chest syndrome in people with sickle cell disease Interventions for treating leg ulcers in people with sickle cell disease Antibiotics for treating acute chest syndrome in people with sickle cell disease Antibiotics for treating osteomyelitis in people with sickle cell disease Interventions for treating leg ulcers in people with sickle cell disease Interventions for treating leg ulcers in people with sickle cell disease Antibiotics for treating acute chest syndrome in people with sickle cell disease Environmental determinants of severity in sickle cell disease Molecular pathophysiology of priapism: emerging targets High Foetal Haemoglobin in Sickle Cell Disease: Not so Protective?Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein Mechanism of testosterone deficiency in the transgenic sickle cell mouse.Early-onset stroke and vasculopathy associated with mutations in ADA2 Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice Doppler velocimetry of the orbital arteries in patients with sickle cell anemia: relationship with biomarkers of hemolysis.Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin.MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.Iron, inflammation, and early death in adults with sickle cell disease.Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease.Pediatric stroke: a review Association between hemolysis and albuminuria in adults with sickle cell anemia Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.Vasculature and kidney complications in sickle cell disease.Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease.The influence of hydroxyurea on oxidative stress in sickle cell anemia Cell-free hemoglobin: a novel mediator of acute lung injury Influence of βS-Globin Haplotypes and Hydroxyurea on Arginase I Levels in Sickle Cell Disease.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

P2860

Q24187279-70A4AB4A-1ADB-4D15-B8E7-C70BA1C27AA4 Q24187355-CEDFEB5F-824C-40AB-8376-B98118CD2FC1 Q24187407-C1EB41F1-F758-40A4-9C3B-BD6E5643539E Q24201706-59A8A8A8-A8E9-4ED8-B6E2-36DC362F1A8B Q24202271-E77266BA-38BF-4787-9BD3-C7C08A9ECAB9 Q24202954-6019EAFE-BD35-42B8-8CF6-E873FA8855B0 Q24239921-0FC3F40F-CDC1-467A-9041-94A7E7B756D8 Q24245501-8B379CFF-914F-474A-ADD2-E573532E6C72 Q26784082-CF1789FA-54A5-4BFA-AABA-79CB8EDDCE07 Q27010069-1B5F2FA2-BCB4-447D-A03A-324CD84C513A Q28080426-18BB9E39-59A9-4CA2-88A1-DBC6D5F1DC91 Q28553088-CE258B9D-C64A-4B7D-A8FE-5F74BBC253A7 Q30389271-EDFD78BC-B6DC-4492-B5C9-92C5612626EA Q30410263-EC52215F-7921-47F7-A346-88576C63C167 Q30525565-2FB31BCE-ED93-4293-8858-338360AA2005 Q33579761-A5A9DEFA-B3AA-43DB-9A20-80ABEF7C8DEC Q33804615-849C01A9-51E7-4124-A238-35C85AFA5270 Q33827417-A3DCB9DE-6AF2-441A-AB82-0127A68E253C Q33873920-8F3E1E90-B97A-475B-8386-DF7D4FD4E7C0 Q33913200-7E263262-14FD-4269-BF39-C9C46FEE1B2D Q34322438-120A5EAC-8E2D-4662-A12A-049387EDBBF1 Q34470834-7EE3C7DF-7C0C-4E3F-A8DC-C1C3B5A27E33 Q34756190-B911FDB0-19F0-472A-8372-4F9F98722985 Q34846466-57DDDA53-A553-4542-9C81-EE7F0FEB9EE1 Q34959995-F933EF94-19DA-4ECD-B22D-210524C96CD3 Q34979516-25BC7F3E-0A0E-4FC9-B368-B16ED2178167 Q35036717-B1E75351-2D53-4B93-9FBC-B7061381706E Q35599915-DCB66A1B-0B0E-4077-87ED-0ED586D5D788 Q35663979-BFF98E5E-DB24-431D-BD16-4B0BB36861E1 Q35717781-31642F95-DA0B-4C28-BEC1-F7BBCF6E54AD Q35754765-B80D8DF1-5F13-45F4-B717-43892D3F4CE0 Q35881838-ECC2BA9B-3D66-4413-8367-C52896499FFB Q35914597-ACCDBBAB-9F9F-4C9E-A6D0-AED1BFC63340 Q35917528-56B0DA0D-0E8C-4EEB-BBAC-8BD929EE5DCA Q36092963-29A53509-3C75-4D5C-8339-2BF2692BB5A9 Q36366564-474AF510-0B5C-468E-85F5-B49964245EA5 Q36534020-FFB6B44C-257C-4C46-B0D0-2B8B61F128B5 Q36698710-97EB028A-158D-4D96-85A9-252E1C6BAD79 Q36909897-496DFFC6-A677-45D2-A0C2-E5412A7EC9E2 Q37033939-145F9733-9B04-4DFB-95C9-1756B36A45AB

P2860

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

http://www.wikidata.org/entity/Q34992760

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Vasculopathy in sickle cell di ...... e, and new research directions

@ast

Vasculopathy in sickle cell di ...... e, and new research directions

@en

Vasculopathy in sickle cell di ...... e, and new research directions

@nl

type

label

Vasculopathy in sickle cell di ...... e, and new research directions

@ast

Vasculopathy in sickle cell di ...... e, and new research directions

@en

Vasculopathy in sickle cell di ...... e, and new research directions

@nl

prefLabel

Vasculopathy in sickle cell di ...... e, and new research directions

@ast

Vasculopathy in sickle cell di ...... e, and new research directions

@en

Vasculopathy in sickle cell di ...... e, and new research directions

@nl

P1433

Q34992760-3C0BEBFE-1455-4727-9F42-CD8DA77DE617

P1476

Q34992760-9F4B199F-E18B-4078-8B46-80331DDA22DC

P2093

Q34992760-863DF14B-C586-41C5-B874-99D4994F12E4

P2860

Q34992760-00B5EAC6-F300-4AE6-8188-F85111D3AE0E

Q34992760-0193507D-32E5-4F53-A268-8927E8910103

Q34992760-03B06098-44BA-4537-A411-6758BA2D174B

Q34992760-0446AB54-959F-4F58-8514-2D98AEBCC76C

Q34992760-05770A9C-3DC3-44D6-92F2-585968D7F639

Q34992760-07F09B31-3E82-458C-97AE-82D85F25EDC4

Q34992760-094E631F-20EC-48A0-BB85-D9DF9829C0B8

Q34992760-0B458DE5-B40E-44FE-B8E0-37E9A973AB37

Q34992760-0BCC4F36-5788-4000-81A0-41BB59DB9907

Q34992760-0C94532D-E153-47FA-9218-DDCDEAB8748E

P304

Q34992760-7A17EAF4-ADA2-418D-9D87-DB547294AE15

P31

Q34992760-D0F1202C-E65B-435A-97A0-979518A38C7C

P356

Q34992760-E6797FA7-A9CD-40C7-B4B1-95DE1B9C36EC

P433

Q34992760-197DBB28-4082-453A-B54B-53CF26B149A0

P478

Q34992760-D74E8B4B-0AD6-4A5D-950D-5BEC37D8A329

P50

Q34992760-37160CA2-3C2B-4D0B-9D02-D8F92B887685

Q34992760-4D919E48-0D1E-4FDF-ABE5-6343060B788E

Q34992760-70B4E3C4-7EA3-4984-BDA3-FE27DD2A7BA8

P577

Q34992760-7E39D1F9-C727-4524-9570-971F9FC6B6B5

P5875

Q34992760-64BAAEAF-73F6-4AF6-9023-984A1A5B4408

P698

Q34992760-4A720044-D1A2-4E3A-9A7A-B770DD1F3EA1

P921

Q34992760-492F6CDD-1C60-4F21-89AF-656C14C15E7F

Q34992760-4C56E43B-E50B-47FD-88EF-DCC8CE543872

P932

Q34992760-20BC76B9-29E6-478A-A428-E28AB5584D80

P356

P1433

American Journal of Hematology

P1476

Vasculopathy in sickle cell di ...... e, and new research directions

@en

P2093

Robert P Hebbel

http://www.w3.org/2001/XMLSchema#string

P2860

Association of polymorphisms of IGF1R and genes in the transforming growth factor- beta /bone morphogenetic protein pathway with bacteremia in sickle cell anemia

Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia

Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910

Hemoglobin and the paracrine and endocrine functions of nitric oxide

Distinct HLA associations by stroke subtype in children with sickle cell anemia

Vascular endothelial cells synthesize nitric oxide from L-arginine

Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation.

Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria.

P304

618-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.21475

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Martin H Steinberg

Gregory J. Kato

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26677808

http://www.w3.org/2001/XMLSchema#string

P698

19610078

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

sickle-cell disease

P932

3209715

http://www.w3.org/2001/XMLSchema#string